Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting
GAITHERSBURG, Md.--(BUSINESS WIRE)--Apr 22, 2024--
Stay updated with breaking news from Melissa Forst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GAITHERSBURG, Md.--(BUSINESS WIRE)--Apr 22, 2024--
Dr. Louis brings to TScan extensive experience in cell therapy, medical affairs, and clinical and commercial developmentWALTHAM, Mass., April 08, 2024 -- TScan Therapeutics, Inc. , a clinical-stage...
On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer in the...
Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and...
GAITHERSBURG, Md., March 28, 2024 -- Cartesian Therapeutics, Inc. , a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced results from a...